| ²é¿´: 1840 | »Ø¸´: 5 | |||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||
Áîºü³å?ÛСÐÜÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
ħµÀÊ¥¾ý
|
[½»Á÷]
¡¾2015ÄêFDAÅú×¼ÐÂÒ©»ã×Ü¡¿ÒÑÓÐ4È˲ÎÓë
|
||||
|
FDA Approved new Drugs in 2015 date time£º2015-2-10 Cardiology/Vascular Diseases Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015 Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015 Dermatology Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Endocrinology Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015 Family Medicine Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015 Hematology Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015 Immunology Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015 Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015 Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015 Infections and Infectious Diseases Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015 Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015 Neurology Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015 Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015 Obstetrics/Gynecology (Women¡¯s Health) Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015 Oncology Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015 Pediatrics/Neonatology Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 Vaccines Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015 |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ò§çïҩѧ | żµÄ |
» ²ÂÄãϲ»¶
¼ºÍª¿É¿É¼î¹ýÑõ»¯ÔÓÖÊÏÞ¶È
ÒѾÓÐ2È˻ظ´
26ÄêÉ격¡ª¡ªÒÑ·¢SCI6ƪ
ÒѾÓÐ13È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ137È˻ظ´
¼î¸×µÄÅäÖÆ
ÒѾÓÐ5È˻ظ´
ÇóÖúIsoeugenolÖÊÁ¿±ê×¼
ÒѾÓÐ0È˻ظ´
Gliclazide
ÒѾÓÐ0È˻ظ´
ÈûÌæÅÉ/àçÌæßߣ¨Thiotepa£© ÖÊÁ¿¿ØÖÆ
ÒѾÓÐ13È˻ظ´
ÓÐûÓдóÀпÉÒÔ°ïæ²éÏÂTrijardy XRºÍQternmet XRÀúÄêÏúÊÛÊý¾Ýѽ
ÒѾÓÐ0È˻ظ´
У¡°ÄÃſƼ¼´óѧ³ÏÕÐ2026ÄêÇï¼¾Ò©¼Áѧ/ÉúÎï²ÄÁÏ·½Ïò²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ14È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÓÃvaspÓÅ»¯Ni2ÍŴسöÏÖµÄÎÊÌ⣡
ÒѾÓÐ18È˻ظ´
ÈçºÎÈüÆËãÀë×Ó´Ó¾§ÌåÄÚ²¿À©É¢µ½±íÃæµÄÄÜÁ¿£¿
ÒѾÓÐ14È˻ظ´
partial chargedensity
ÒѾÓÐ21È˻ظ´
ÅÝÄÄø×ö¼¯Á÷Ì壬ûÓÐÍ¿»îÐÔÎïÖʵÄÒ»ÃæÓò»Ó÷âס£¿£¿£¿
ÒѾÓÐ22È˻ظ´
ÇóÖúÄÉÃ׿ÅÁ£FeÑõ»¯ÎïµÄXPS·ÖÎö
ÒѾÓÐ16È˻ظ´
Çó¸÷λ´óÉñ°ïÎÒ¿´ÏÂÒ»¸öССµÄ³ÌÐò£¬Ö»ÐèÒªÄãÒ»µã¶ùʱ¼ä¡£¾Í»á°ïÎҺܴóµÄæ
ÒѾÓÐ15È˻ظ´
°±»ùÓëäåÒÒËáÉú³É°±»ùÒÒËáÌõ¼þ
ÒѾÓÐ32È˻ظ´

gatzz_0827
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 426.5
- ºì»¨: 1
- ɳ·¢: 3
- Ìû×Ó: 488
- ÔÚÏß: 691.1Сʱ
- ³æºÅ: 1155587
- ×¢²á: 2010-11-25
- ÐÔ±ð: GG
- רҵ: ͼÊé¹Ý¡¢Ç鱨ÓëÎÄÏ×ѧÆäËû
5Â¥2015-02-12 09:17:37
³ô±¿±¿
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 82 (³õÖÐÉú)
- ½ð±Ò: 1771.3
- É¢½ð: 219
- ºì»¨: 3
- Ìû×Ó: 834
- ÔÚÏß: 205.2Сʱ
- ³æºÅ: 3064652
- ×¢²á: 2014-03-17
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
2Â¥2015-02-10 19:46:47
ÁèÓîÀ׳Ø
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
Сľ³æ¿ÆÑдóʹ\(^o^)/~
- DRDEPI: 1
- Ó¦Öú: 758 (²©ºó)
- ¹ó±ö: 160.549
- ½ð±Ò: 297904
- É¢½ð: 91930
- ºì»¨: 1118
- ɳ·¢: 3411
- Ìû×Ó: 92918
- ÔÚÏß: 54127.7Сʱ
- ³æºÅ: 659100
- ×¢²á: 2008-11-21
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
- ¹ÜϽ: ¿ÆÑÐÉú»îÇø

3Â¥2015-02-11 08:30:25
Áîºü³å?ÛСÐÜ
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
ħµÀÊ¥¾ý
- Ó¦Öú: 68 (³õÖÐÉú)
- ½ð±Ò: 18401.3
- É¢½ð: 15
- ºì»¨: 59
- Ìû×Ó: 5738
- ÔÚÏß: 339.8Сʱ
- ³æºÅ: 1327490
- ×¢²á: 2011-06-20
- ÐÔ±ð: GG
- רҵ: É«Æ×·ÖÎö

6Â¥2015-02-12 09:40:05













»Ø¸´´ËÂ¥

